Effects of ORG 2766 on Vincristine Cytotoxicity in Lymphoma Cells
Author Information
Author(s): B. Kiburg, A.A. van de Loosdrecht, K.M. Schweitzer, G.J. Ossenkoppele, L.J. Muller, J.J. Heimans, P.C. Huijgens
Primary Institution: Free University Hospital, Amsterdam, The Netherlands
Hypothesis
Does the ACTH(4-9) analogue ORG 2766 affect vincristine cytotoxicity in human lymphoma cell lines?
Conclusion
ORG 2766 does not negatively interfere with vincristine-mediated cytotoxicity and may enhance its effects.
Supporting Evidence
- ORG 2766 alone had no effect on cell growth and survival.
- ORG 2766 did not affect vincristine cytotoxicity.
- After 96 hours of pretreatment with ORG 2766, a reduction in residual growth was observed.
- ORG 2766 enhanced the cytostatic effect of vincristine.
Takeaway
This study looked at whether a drug called ORG 2766 helps or hurts another drug called vincristine that fights cancer. It found that ORG 2766 doesn't hurt vincristine's ability to work.
Methodology
The study used MTT-based assays to assess the effects of ORG 2766 on cell growth and vincristine cytotoxicity in U937 and U715 lymphoma cell lines.
Limitations
The study involved only two cell lines and did not include a large patient sample.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website